Shanghai M&G Stationery Inc. (SHA:603899)
China · Delayed Price · Currency is CNY 27.62
-0.10 (-0.36%)
At close: Feb 6, 2026
Shanghai M&G Stationery Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 24,384 | 24,171 | 23,303 | 19,986 | 17,602 | 13,134 |
Other Revenue | 57.59 | 57.59 | 48.65 | 10.05 | 5.32 | 4.2 |
| 24,442 | 24,228 | 23,351 | 19,996 | 17,607 | 13,138 | |
Revenue Growth (YoY) | -0.67% | 3.75% | 16.78% | 13.57% | 34.02% | 17.92% |
Cost of Revenue | 19,851 | 19,651 | 18,935 | 16,141 | 13,538 | 9,817 |
Gross Profit | 4,591 | 4,577 | 4,416 | 3,855 | 4,069 | 3,321 |
Selling, General & Admin | 2,848 | 2,720 | 2,367 | 2,152 | 2,143 | 1,706 |
Research & Development | 191.83 | 189.15 | 177.53 | 183.55 | 188.76 | 160.18 |
Other Operating Expenses | 101.77 | 69.04 | 96.77 | 75.59 | 66.51 | 50.69 |
Operating Expenses | 3,166 | 3,000 | 2,658 | 2,429 | 2,382 | 1,942 |
Operating Income | 1,426 | 1,577 | 1,758 | 1,427 | 1,687 | 1,379 |
Interest Expense | -28.24 | -27.33 | -25 | -14.76 | -22.85 | -6.95 |
Interest & Investment Income | 52.88 | 64.18 | 76.35 | 39.21 | 38.09 | 17.27 |
Currency Exchange Gain (Loss) | 11.52 | 11.52 | 10.7 | 22.21 | -9.48 | -12.09 |
Other Non Operating Income (Expenses) | 48.33 | -15.51 | -12.45 | 20.09 | -28.35 | -16.01 |
EBT Excluding Unusual Items | 1,510 | 1,609 | 1,808 | 1,493 | 1,665 | 1,361 |
Impairment of Goodwill | - | - | - | - | - | -30.18 |
Gain (Loss) on Sale of Investments | 59.21 | 54 | 23.26 | 31.84 | 38.64 | 32.28 |
Gain (Loss) on Sale of Assets | -1.53 | 0.01 | 3.6 | -0.03 | 6.1 | 0.17 |
Asset Writedown | -17.09 | -17.09 | -1.86 | -6.02 | -5.25 | -2.6 |
Other Unusual Items | 174.91 | 174.91 | 146.76 | 145.79 | 157.29 | 156.57 |
Pretax Income | 1,726 | 1,821 | 1,979 | 1,665 | 1,861 | 1,517 |
Income Tax Expense | 365.65 | 366.52 | 335.53 | 309.52 | 327.81 | 278.78 |
Earnings From Continuing Operations | 1,360 | 1,455 | 1,644 | 1,355 | 1,534 | 1,238 |
Minority Interest in Earnings | -37.36 | -58.89 | -117.14 | -72.92 | -15.73 | 17.05 |
Net Income | 1,323 | 1,396 | 1,527 | 1,282 | 1,518 | 1,255 |
Net Income to Common | 1,323 | 1,396 | 1,527 | 1,282 | 1,518 | 1,255 |
Net Income Growth | -9.06% | -8.58% | 19.05% | -15.51% | 20.90% | 18.43% |
Shares Outstanding (Basic) | 915 | 921 | 921 | 923 | 921 | 920 |
Shares Outstanding (Diluted) | 915 | 921 | 921 | 924 | 921 | 926 |
Shares Change (YoY) | -0.60% | -0.05% | -0.30% | 0.29% | -0.52% | 0.66% |
EPS (Basic) | 1.45 | 1.52 | 1.66 | 1.39 | 1.65 | 1.36 |
EPS (Diluted) | 1.45 | 1.52 | 1.66 | 1.39 | 1.64 | 1.36 |
EPS Growth | -8.52% | -8.53% | 19.48% | -15.53% | 21.15% | 17.66% |
Free Cash Flow | 1,844 | 1,960 | 2,408 | 1,189 | 1,179 | 947.76 |
Free Cash Flow Per Share | 2.02 | 2.13 | 2.62 | 1.29 | 1.28 | 1.02 |
Dividend Per Share | 1.000 | 1.000 | 0.800 | 0.500 | 0.600 | 0.500 |
Dividend Growth | 25.00% | 25.00% | 60.00% | -16.67% | 20.00% | 25.00% |
Gross Margin | 18.78% | 18.89% | 18.91% | 19.28% | 23.11% | 25.28% |
Operating Margin | 5.83% | 6.51% | 7.53% | 7.13% | 9.58% | 10.49% |
Profit Margin | 5.41% | 5.76% | 6.54% | 6.41% | 8.62% | 9.56% |
Free Cash Flow Margin | 7.54% | 8.09% | 10.31% | 5.95% | 6.70% | 7.21% |
EBITDA | 1,646 | 1,806 | 2,000 | 1,671 | 1,913 | 1,571 |
EBITDA Margin | 6.74% | 7.46% | 8.56% | 8.36% | 10.86% | 11.96% |
D&A For EBITDA | 220.87 | 229.71 | 241.5 | 244.9 | 225.45 | 192.36 |
EBIT | 1,426 | 1,577 | 1,758 | 1,427 | 1,687 | 1,379 |
EBIT Margin | 5.83% | 6.51% | 7.53% | 7.13% | 9.58% | 10.49% |
Effective Tax Rate | 21.19% | 20.13% | 16.95% | 18.59% | 17.61% | 18.38% |
Revenue as Reported | 24,442 | 24,228 | 23,351 | 19,996 | 17,607 | 13,138 |
Advertising Expenses | - | 174.53 | 141.56 | 111.91 | 113.83 | 87.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.